Cargando…

Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels

Context: Dihydromyricetin (DMY) has oxidation resistance, anti-inflammatory and free radical scavenging capabilities. The preventive effects of DMY for vascular hyporeactivity remain unclear. Objective: This study investigates the preventive effects of DMY in vascular hyporeactivity. Materials and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jin, Zhang, Jian, Zhang, Li, Tian, Yonggang, Li, Yahong, Qiao, Lujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130638/
https://www.ncbi.nlm.nih.gov/pubmed/30003825
http://dx.doi.org/10.1080/13880209.2018.1478430
_version_ 1783353977521307648
author Peng, Jin
Zhang, Jian
Zhang, Li
Tian, Yonggang
Li, Yahong
Qiao, Lujun
author_facet Peng, Jin
Zhang, Jian
Zhang, Li
Tian, Yonggang
Li, Yahong
Qiao, Lujun
author_sort Peng, Jin
collection PubMed
description Context: Dihydromyricetin (DMY) has oxidation resistance, anti-inflammatory and free radical scavenging capabilities. The preventive effects of DMY for vascular hyporeactivity remain unclear. Objective: This study investigates the preventive effects of DMY in vascular hyporeactivity. Materials and methods: The experimental sepsis was induced by transvenous administration of lipopolysaccharide (LPS) to Sprague–Dawley (SD) rats. DMY-treated rats received daily administration of DMY, 5 μg/kg dissolved in DMSO through the tail vein for 7 days. The invasive mean arterial pressure (MAP) of the caudal ventral artery was measured. Dose-response curves for norepinephrine (NE, doses from 10(−9) to 10(−6 )M) were obtained in isolated thoracic aorta in a cumulative manner. The function of MaxiK and K(ATP) channels were investigated using whole-cell patch clamp recording. The Elisa was adopted to measure the serum concentration of NO, MDA, 3-NT, IL-1β and TNF-α. Results: The increased MAP in septic rats induced by vasopressor agents was smaller than that in control rats. However, the % of increased MAP induced by vasopressor agents was raised by DMY injection (NE: 20.4 ± 8.495 vs. 15.16 ± 5.195%; AVP: 14.05 ± 2.459 vs. 9.583 ± 2.982%, p < 0.05). The vascular hyporesponsiveness to NE (10(−6 )M) in vitro. was increased by 51% in LPS + DMY group compared with that in LPS + Con group (2.74 ± 0.81 vs. 1.82 ± 0.92 g, p < 0.05). Charybdotoxin (a potent MaxiK channel blocker) and glibenclamide (a K(ATP) channel blocker) pretreatment, instead of 4-aminopyridine (4-AP) and BaCl(2), could diminish the DMY-induced improvement of vasoconstrictor hyporeactivity (ChTX: 73.2 ± 11.8 vs. 71.8 ± 13.5%; Glib: 63.1 ± 12.5 vs. 58.1 ± 13.7%, p > 0.05). DMY blunted the highly sensitized MaxiK and K(ATP) channels of arterial smooth muscle cells isolated from the thoracic aorta of LPS rats. DMY decreased the serum level of NO, MDA, IL-1β and TNF-α, which had increased in LPS rats. Discussion and conclusions: Our results indicate that DMY administration ameliorated the impaired contractility of the rat aorta in experimental sepsis. Such an effect is mediated by normalization of the over-excited MaxiK and K(ATP), channels possibly via oxidative stress inhibition.
format Online
Article
Text
id pubmed-6130638
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-61306382018-09-27 Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels Peng, Jin Zhang, Jian Zhang, Li Tian, Yonggang Li, Yahong Qiao, Lujun Pharm Biol Research Article Context: Dihydromyricetin (DMY) has oxidation resistance, anti-inflammatory and free radical scavenging capabilities. The preventive effects of DMY for vascular hyporeactivity remain unclear. Objective: This study investigates the preventive effects of DMY in vascular hyporeactivity. Materials and methods: The experimental sepsis was induced by transvenous administration of lipopolysaccharide (LPS) to Sprague–Dawley (SD) rats. DMY-treated rats received daily administration of DMY, 5 μg/kg dissolved in DMSO through the tail vein for 7 days. The invasive mean arterial pressure (MAP) of the caudal ventral artery was measured. Dose-response curves for norepinephrine (NE, doses from 10(−9) to 10(−6 )M) were obtained in isolated thoracic aorta in a cumulative manner. The function of MaxiK and K(ATP) channels were investigated using whole-cell patch clamp recording. The Elisa was adopted to measure the serum concentration of NO, MDA, 3-NT, IL-1β and TNF-α. Results: The increased MAP in septic rats induced by vasopressor agents was smaller than that in control rats. However, the % of increased MAP induced by vasopressor agents was raised by DMY injection (NE: 20.4 ± 8.495 vs. 15.16 ± 5.195%; AVP: 14.05 ± 2.459 vs. 9.583 ± 2.982%, p < 0.05). The vascular hyporesponsiveness to NE (10(−6 )M) in vitro. was increased by 51% in LPS + DMY group compared with that in LPS + Con group (2.74 ± 0.81 vs. 1.82 ± 0.92 g, p < 0.05). Charybdotoxin (a potent MaxiK channel blocker) and glibenclamide (a K(ATP) channel blocker) pretreatment, instead of 4-aminopyridine (4-AP) and BaCl(2), could diminish the DMY-induced improvement of vasoconstrictor hyporeactivity (ChTX: 73.2 ± 11.8 vs. 71.8 ± 13.5%; Glib: 63.1 ± 12.5 vs. 58.1 ± 13.7%, p > 0.05). DMY blunted the highly sensitized MaxiK and K(ATP) channels of arterial smooth muscle cells isolated from the thoracic aorta of LPS rats. DMY decreased the serum level of NO, MDA, IL-1β and TNF-α, which had increased in LPS rats. Discussion and conclusions: Our results indicate that DMY administration ameliorated the impaired contractility of the rat aorta in experimental sepsis. Such an effect is mediated by normalization of the over-excited MaxiK and K(ATP), channels possibly via oxidative stress inhibition. Taylor & Francis 2018-07-13 /pmc/articles/PMC6130638/ /pubmed/30003825 http://dx.doi.org/10.1080/13880209.2018.1478430 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Peng, Jin
Zhang, Jian
Zhang, Li
Tian, Yonggang
Li, Yahong
Qiao, Lujun
Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels
title Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels
title_full Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels
title_fullStr Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels
title_full_unstemmed Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels
title_short Dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited MaxiK and K(ATP) channels
title_sort dihydromyricetin improves vascular hyporesponsiveness in experimental sepsis via attenuating the over-excited maxik and k(atp) channels
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130638/
https://www.ncbi.nlm.nih.gov/pubmed/30003825
http://dx.doi.org/10.1080/13880209.2018.1478430
work_keys_str_mv AT pengjin dihydromyricetinimprovesvascularhyporesponsivenessinexperimentalsepsisviaattenuatingtheoverexcitedmaxikandkatpchannels
AT zhangjian dihydromyricetinimprovesvascularhyporesponsivenessinexperimentalsepsisviaattenuatingtheoverexcitedmaxikandkatpchannels
AT zhangli dihydromyricetinimprovesvascularhyporesponsivenessinexperimentalsepsisviaattenuatingtheoverexcitedmaxikandkatpchannels
AT tianyonggang dihydromyricetinimprovesvascularhyporesponsivenessinexperimentalsepsisviaattenuatingtheoverexcitedmaxikandkatpchannels
AT liyahong dihydromyricetinimprovesvascularhyporesponsivenessinexperimentalsepsisviaattenuatingtheoverexcitedmaxikandkatpchannels
AT qiaolujun dihydromyricetinimprovesvascularhyporesponsivenessinexperimentalsepsisviaattenuatingtheoverexcitedmaxikandkatpchannels